Saturday marks the third anniversary of the powerful earthquake that destroyed much of the Haitian capital, Port-au-Prince. The quake killed roughly 200,000 people and left 1.5 million Haitians homeless.
Despite billions of dollars in international aid and pledges to help Haiti rebuild from the disaster, very little new, permanent housing has been built. And about 350,000 Haitians are still living in squalid, makeshift camps — where they face an array of health challenges.
Federal healthy officials said Friday there are some early signs this year's flu season may be easing in some parts of the country. But they stressed it's far too early to tell whether the flu season has peaked.
The number of states reporting widespread flu activity is up to 47, according to the Centers for Disease Control and Prevention. But flu activity nationally fell slightly in the CDC's most recent data. Five states reported less flu than a week earlier, according to the CDC.
Originally published on Mon January 14, 2013 7:06 am
Why would the Defense Advanced Research Projects Agency — the people who helped bring the world stealth fighters and GPS — fund research into man-made proteins that could make it easier for some Americans to eat pizza?
That's what we wondered when we read that the Pentagon's gee-whiz research arm provided support for work on a drug to treat celiac disease, a condition that interferes with the digestion of gluten in wheat and other foods.
Originally published on Fri January 11, 2013 9:29 am
By Scott Hensley
Drugmaker Merck just stuck a fork in a vitamin-based drug to prevent heart disease and stroke.
The company is withdrawing Tredaptive, a long-acting pill combining niacin (No. 3 in the long list of B vitamins) and laropiprant, a chemical that reduces the unpleasant skin flushing caused by high doses of niacin.